Search results
Displaying 21 - 30 of 35 results
-
Pharmac leaflet explaining medicine brand changes
This leaflet from Pharmac explains why brand names, appearance and packaging of your medicines may have changed.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Gary's story: a consumer perspective on taking warfarin
This is the story of Gary Edwards, a 60-year-old builder from Waitarere Beach, who ended up on Warfarin after a cardiac event.
-
Medicine reconciliation guidance tools and training materials
Medicine reconciliation guidance tools and training materials.
-
Consumer flyer: Ask your pharmacist for advice about your medicines
Consumer flyer: help with your medicines is available – ask your pharmacist for advice.
-
Safe use of opioids collaborative information for DHB hospitals
Information document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Evaluation of the safe use of opioids national collaborative
This report presents an evaluation of the Health Quality & Safety Commission-led safe use of opioids national collaborative.
-
Safe Medication Management newsletters - 2010
Newsletters from the SMM programme for the year 2010
-
Consumer research: Safer prescribing and dispensing of medicines
Te Tāhū Hauora Health Quality & Safety Commission (Te Tāhū Hauora) is working alongside other agencies to support safer prescribing and dispensing of medicines. The full report on this project and a summary of the report are available here.